Published in Cell Microbiol on August 01, 2000
Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. Proc Natl Acad Sci U S A (2005) 2.45
Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev (2014) 2.20
Differential recognition of surface proteins in Streptococcus pyogenes by two sortase gene homologs. J Bacteriol (2002) 1.88
Emergence of a New Highly Successful Acapsular Group A Streptococcus Clade of Genotype emm89 in the United Kingdom. MBio (2015) 1.54
Group A Streptococcus gene expression in humans and cynomolgus macaques with acute pharyngitis. Infect Immun (2003) 1.53
Capsules, toxins and AtxA as virulence factors of emerging Bacillus cereus biovar anthracis. PLoS Negl Trop Dis (2015) 1.51
OspE-related, OspF-related, and Elp lipoproteins are immunogenic in baboons experimentally infected with Borrelia burgdorferi and in human lyme disease patients. J Clin Microbiol (2002) 1.41
Cytolysin-dependent evasion of lysosomal killing. Proc Natl Acad Sci U S A (2005) 1.35
Cytotoxic effects of streptolysin o and streptolysin s enhance the virulence of poorly encapsulated group a streptococci. Infect Immun (2003) 1.34
Central role of a bacterial two-component gene regulatory system of previously unknown function in pathogen persistence in human saliva. Proc Natl Acad Sci U S A (2005) 1.33
Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein. J Exp Med (2003) 1.33
CD44 as a receptor for colonization of the pharynx by group A Streptococcus. J Clin Invest (2000) 1.30
Human disease isolates of serotype m4 and m22 group a streptococcus lack genes required for hyaluronic acid capsule biosynthesis. MBio (2012) 1.27
Streptococcus pneumoniae can utilize multiple sources of hyaluronic acid for growth. Infect Immun (2012) 1.12
PerR confers phagocytic killing resistance and allows pharyngeal colonization by group A Streptococcus. PLoS Pathog (2008) 1.10
Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection. Infect Immun (2001) 1.06
Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules. FEMS Microbiol Rev (2014) 1.05
Cleavage of antigen-bound immunoglobulin G by SpeB contributes to streptococcal persistence in opsonizing blood. Infect Immun (2003) 1.04
Tissue tropisms in group A streptococcal infections. Future Microbiol (2010) 1.03
Role of Mga in group A streptococcal infection at the skin epithelium. Microb Pathog (2008) 1.00
Group A Streptococcus secreted esterase hydrolyzes platelet-activating factor to impede neutrophil recruitment and facilitate innate immune evasion. PLoS Pathog (2012) 0.98
Neutrophils select hypervirulent CovRS mutants of M1T1 group A Streptococcus during subcutaneous infection of mice. Infect Immun (2014) 0.93
Regulation of inhibition of neutrophil infiltration by the two-component regulatory system CovRS in subcutaneous murine infection with group A streptococcus. Infect Immun (2013) 0.91
Asymptomatic carriage of group A streptococcus is associated with elimination of capsule production. Infect Immun (2014) 0.91
Regulation of streptokinase expression by CovR/S in Streptococcus pyogenes: CovR acts through a single high-affinity binding site. Microbiology (2009) 0.91
Natural variation in the promoter of the gene encoding the Mga regulator alters host-pathogen interactions in group a Streptococcus carrier strains. Infect Immun (2013) 0.88
The M protein is dispensable for maturation of streptococcal cysteine protease SpeB. Infect Immun (2005) 0.86
Functional dissection of Streptococcus pyogenes M5 protein: the hypervariable region is essential for virulence. PLoS One (2009) 0.86
Characterization of streptococcal platelet-activating factor acetylhydrolase variants that are involved in innate immune evasion. Infect Immun (2013) 0.84
Sortase A induces Th17-mediated and antibody-independent immunity to heterologous serotypes of group A streptococci. PLoS One (2014) 0.83
Mutual exclusivity of hyaluronan and hyaluronidase in invasive group A Streptococcus. J Biol Chem (2014) 0.80
The contribution of non-human primate models to the development of human vaccines. Discov Med (2014) 0.79
Hyaluronic acid derived from other streptococci supports Streptococcus pneumoniae in vitro biofilm formation. Biomed Res Int (2013) 0.79
The lack of genetic association of the Toll-like receptor 2 (TLR2) Arg753Gln and Arg677Trp polymorphisms with rheumatic heart disease. Clin Rheumatol (2006) 0.76
Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models. MBio (2016) 0.75
Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins. J Virol (1987) 5.03
Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal. Cell (1986) 4.56
Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J (1986) 4.32
Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci U S A (1987) 3.99
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci (1999) 3.85
Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol Microbiol (1998) 3.84
Natural infection of Suffolk sheep with scrapie virus. J Infect Dis (1982) 3.42
Pathogenesis of scrapie virus infection in the mouse. J Infect Dis (1967) 3.34
Aleutian disease of mink: properties of the etiologic agent and the host responses. J Infect Dis (1968) 3.03
Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect Immun (1992) 2.73
Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J Clin Invest (1996) 2.57
Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest (1998) 2.47
Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen. J Biol Chem (1987) 2.35
Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science (1986) 2.33
Functional analysis in type Ia group B Streptococcus of a cluster of genes involved in extracellular polysaccharide production by diverse species of streptococci. J Biol Chem (2001) 2.30
Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus. Infect Immun (1997) 2.13
Identification of cpsD, a gene essential for type III capsule expression in group B streptococci. Mol Microbiol (1993) 2.09
Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. Virology (1988) 2.05
Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest (1996) 2.05
The changing spectrum of group B streptococcal disease. N Engl J Med (1993) 1.94
Virologic and neurohistologic findings in dairy goats affected with natural scrapie. Vet Pathol (1980) 1.88
Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. J Clin Invest (1998) 1.87
Atypical mycobacterial infection caused by Mycobacterium marinum. N Engl J Med (1990) 1.79
Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect Immun (1996) 1.79
Comparative pathogenicity of four strains of Aleutian disease virus for pastel and sapphire mink. Infect Immun (1983) 1.77
Characterization of PEDF: a multi-functional serpin family protein. J Cell Biochem (2009) 1.77
Group A Streptococcus tissue invasion by CD44-mediated cell signalling. Nature (2001) 1.76
Reduction of incorrect antibiotic dosing through a structured educational order form. Arch Intern Med (1988) 1.59
Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun (1994) 1.53
Immune response to hepatitis B surface antigen: enhancement by prior injection of antibodies to the idiotype. Science (1983) 1.48
Prevention and emergency field management of venomous snakebites during military exercises. Mil Med (1990) 1.48
Isolation of a virus from the lungs of Montana sheep affected with progressive pneumonia. Virology (1968) 1.46
The phosphatidylinositol kinase of rat brain. Biochem J (1966) 1.45
Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates. J Clin Invest (1992) 1.45
Obstetric fistula in rural Ethiopia. East Afr Med J (2007) 1.38
Common idiotypic determinant associated with human antibodies to hepatitis B surface antigen. J Immunol (1983) 1.38
Biotin-avidin-amplified enzyme immunoassay for detection of herpes simplex virus antigen in clinical specimens. J Clin Microbiol (1983) 1.36
Course of experimental scrapie virus infection in the goat. J Infect Dis (1974) 1.36
Enhancement of the immune response to hepatitis B surface antigen. In vivo administration of antiidiotype induces anti-HBs that expresses a similar idiotype. J Exp Med (1984) 1.35
Structure of the has operon promoter and regulation of hyaluronic acid capsule expression in group A Streptococcus. Mol Microbiol (1998) 1.30
Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis (1999) 1.30
CD44 as a receptor for colonization of the pharynx by group A Streptococcus. J Clin Invest (2000) 1.30
Isolation and characterization of simian immunodeficiency viruses from two subspecies of African green monkeys. AIDS Res Hum Retroviruses (1990) 1.29
Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun (1992) 1.27
Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical 1% apraclonidine. Arch Ophthalmol (1988) 1.26
Molecular analysis of the capsule gene region of group A Streptococcus: the hasAB genes are sufficient for capsule expression. J Bacteriol (1998) 1.26
Relation of the Escherichia coli dnaX gene to its two products--the tau and gamma subunits of DNA polymerase III holoenzyme. Nucleic Acids Res (1987) 1.25
A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein. Infect Immun (1994) 1.24
Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees. Science (1986) 1.24
Comparison and characterization of immunoglobulin G subclasses among primate species. Clin Diagn Lab Immunol (1999) 1.21
Characterization of the linkage between the type III capsular polysaccharide and the bacterial cell wall of group B Streptococcus. J Biol Chem (2000) 1.21
An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus. J Biol Chem (1990) 1.18
Application of a modified computer algorithm in determining potential antigenic determinants associated with the AIDS virus glycoprotein. Anal Biochem (1985) 1.15
Nonhuman primate models to evaluate vaccine safety and immunogenicity. Vaccine (1997) 1.14
The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6) Id and anti-polynucleotide activity. Clin Exp Immunol (1987) 1.12
Fungal metabolism and detoxification of the nitropolycyclic aromatic hydrocarbon 1-nitropyrene. Appl Environ Microbiol (1985) 1.12
Induction of an anti-hepatitis B surface antigen response in mice by noninternal image (Ab2 alpha) anti-idiotypic antibodies. J Immunol (1987) 1.11
Fungal metabolism and detoxification of polycyclic aromatic hydrocarbons. Arch Microbiol (1985) 1.10
Characterization of cpsF and its product CMP-N-acetylneuraminic acid synthetase, a group B streptococcal enzyme that can function in K1 capsular polysaccharide biosynthesis in Escherichia coli. Mol Microbiol (1996) 1.10
Regulation of capsule gene expression by group A Streptococcus during pharyngeal colonization and invasive infection. Mol Microbiol (2001) 1.10
Temporal distribution of transmissible mink encephalopathy virus in mink inoculated subcutaneously. J Virol (1987) 1.08
Antibody to hepatitis B virus induced by injecting antibodies to the idiotype. Science (1984) 1.08
Survival of primates in LD100 septic shock following steroid/antibiotic therapy. J Surg Res (1980) 1.07
Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides. J Immunol (1985) 1.07
Use of a resin-bound synthetic peptide for identifying a neutralizing antigenic determinant associated with the human immunodeficiency virus envelope. J Biol Chem (1987) 1.07
Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection. Infect Immun (2001) 1.06
A comparison of ketamine and the combination ketamine-xylazine for effective surgical anesthesia in the rabbit. Lab Anim Sci (1976) 1.06
Group B streptococcal opacity variants. J Bacteriol (1992) 1.05
Phosphoinositide metabolism in rat superior cervical ganglion, vagus and phrenic nerve: effects of electrical stimulation and various blocking agents. J Neurochem (1974) 1.05
The detection of a common idiotype of anti-DNA antibodies in the sera of patients with monoclonal gammopathies. J Clin Immunol (1986) 1.04
Royal pastel mink respond variously to inoculation with Aleutian disease virus of low virulence. J Virol (1984) 1.04
Monoclonal anti-idiotypic antibody mimics the CD4 receptor and binds human immunodeficiency virus. Proc Natl Acad Sci U S A (1987) 1.03
Expression and immunogenicity of an 18-residue epitope of HIV1 gp41 inserted in the flagellar protein of a Salmonella live vaccine. Res Microbiol (1995) 1.03
HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: possible pathway for HIV entry into the brain and HIV-associated dementia. J Neuropathol Exp Neurol (2002) 1.03
A chemically defined liquid medium that supports primary isolation of Rochalimaea (Bartonella) henselae from blood and tissue specimens. J Clin Microbiol (1995) 1.03
Epitopes associated with a synthetic hepatitis B surface antigen peptide. J Immunol (1983) 1.02
Detection of interspecies idiotypic cross-reactions associated with antibodies to hepatitis B surface antigen. Eur J Immunol (1983) 1.02
Production and characterization of anti-idiotype reagents for the analysis of viral antigen systems. J Virol Methods (1983) 1.01
A common anti-DNA idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum (1987) 1.01
Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1. J Virol (1996) 1.01
Expression and characterization of hepatitis B virus surface antigen polypeptides in insect cells with a baculovirus expression system. J Virol (1989) 1.01
Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody. J Trauma (1992) 1.00
Hormones, receptors, and cyclic AMP: their role in target cell refractoriness. Curr Top Cell Regul (1980) 1.00
Differences between agonist and antagonist binding following beta-adrenergic receptor desensitization. J Biol Chem (1978) 0.99
Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies. J Exp Med (1985) 0.99
Anti-idiotypic antibodies: implications of internal image-based vaccines for infectious diseases. J Infect Dis (1985) 0.98
Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci. Infect Immun (1993) 0.98
Structural characterization of viral neutralizing monoclonal antibodies to hepatitis B surface antigen. Mol Immunol (1998) 0.98
Anti-idiotypic antibodies as immunogens: idiotype-based vaccines. Vaccine (1988) 0.97
Synthetic peptides define the fine specificity of the human immunodeficiency virus (HIV) gp160 humoral immune response in HIV type 1-infected chimpanzees. J Virol (1990) 0.96
Adenovirus keratitis: a role for interleukin-8. Invest Ophthalmol Vis Sci (2000) 0.96
HIV-induced syncytia of a T cell line form single giant pseudopods and are motile. J Cell Sci (1993) 0.96
T cell syncytia induced by HIV release. T cell chemoattractants: demonstration with a newly developed single cell chemotaxis chamber. J Cell Sci (1998) 0.96
Nuclei number in human embryos co-cultured with human ampullary cells. Hum Reprod (1996) 0.96